46.26 USD
▲+0.31+7.23%
盘后 43.02 -0.29%
2026-08-03
市值
$127.32M
市盈率
—
EPS
-38.62
股息率
—
52 周区间
7.00 – 240.00
成交量
63.24K
Beta
3.34
目标价
151.00
52W 低 7.0052W 高 240.00
价格走势
公司简介
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sle...